Healthcare schemes for Hemodialysis patients in India: An Overview and Utilization in selected hospitals

Author:

Naik Gangadhar1,Ligade Virendra1,Prasad Shankar2,Guddattu Vasudeva3,D Sreedhar1

Affiliation:

1. Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal – 576104.

2. Department of Nephrology, Kasturba Hospital, Manipal Academy of Higher Education, Manipal – 576104.

3. Department of Data Science, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal – 576104.

Abstract

In India, end-stage renal disease (ESRD) complications have attained pervasive dimensions, and it is estimated that rates of illness will continue to increase in the future. When both kidneys are failing, it is like being sentenced to death and lifetime hemodialysis (HD) is the only possible solution. Hardly 10% of sufferers from ESRD throughout India are obtaining HD because of the difficulties encountered. The ESRD catastrophe in the young generation of working professionals is a huge socio-economical concern. End-stage renal failure is a result of various non-contagious ailments. As per the worldwide incidence of illness, chronic renal impairment was the ninth greatest standard trigger of the disease in India. Annually in India, encounter about 2.2 lakhs new patients with kidney disorders. The main impediments in obtaining proper therapy inter alia are enormous costs in corporate hospitals, facilities for the treatment in metro cities, a confined number of Nephrologists, etc. Approximately 4950 hemodialysis hubs are located under corporate stakeholders in India. Every single hemodialysis costs approx. INR 2000, which when calculated costs about INR 3-4 LPA. HD is effective medical care for ESRD. The outlay is at all the time important problem for HD sufferers. Moreover, the majority of the hemodialysis patients require an attendant from family amounting to a further increase in the cost. It has been considered that in respect of both, determining these life-significant life-saving techniques as well as for diminishing destitution on the attention of ongoing costs for sufferers, a healthcare scheme is imperative for hemodialysis patients. Renal replacement therapy (RRT) treatment within India is largely a privatize medical assistance enterprise making this a costly therapy option because of huge out-of-pocket outlays. At this stage, the vast majority of HD sufferers in India die without obtaining a suitable prognosis. There are a handful of healthcare schemes provided by the Central Government, State Governments, NGOs, and even hospitals. However, there is a dire need to bring awareness among the public and the benefits that each scheme provides.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Peritoneal Dialysis in Newborns with Cardiac Surgery AKI;Salud, Ciencia y Tecnología;2024-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3